Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy
Reactive oxygen species (ROS) can promote or inhibit tumorigenesis. In mesothelioma, asbestos exposure to serous membranes induces ROS through iron content and chronic inflammation, and ROS promote cell survival signaling in mesothelioma. Moreover, a current chemotherapy regimen for mesothelioma con...
Main Authors: | Derek B. Oien, Tamás Garay, Sarah Eckstein, Jeremy Chien |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2017.00970/full |
Similar Items
-
AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction
by: Lea Landolt, et al.
Published: (2019-05-01) -
Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer Progression
by: Anne von Mässenhausen, et al.
Published: (2016-12-01) -
AXL Inactivation Inhibits Mesothelioma Growth and Migration via Regulation of p53 Expression
by: Wei Song, et al.
Published: (2020-09-01) -
In Vitro Characterization of Cisplatin and Pemetrexed Effects in Malignant Pleural Mesothelioma 3D Culture Phenotypes
by: Eleftherios D. Papazoglou, et al.
Published: (2019-09-01) -
A Case of Posterior Reversible Encephalopathy Syndrome Induced by Cisplatin/Pemetrexed Chemotherapy for Lung Cancer
by: Masashi Ishihara, et al.
Published: (2017-03-01)